This Single-Use Bio Reactors report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The single-use bio reactors market size has grown rapidly in recent years. It will grow from $5.26 billion in 2024 to $6.23 billion in 2025 at a compound annual growth rate (CAGR) of 18.3%. The growth in the historic period can be attributed to biopharmaceutical industry growth, rapid bioprocess development, regulatory support, high adoption rates of precision medicine, rise in healthcare infrastructure.
The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $13.68 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to personalized medicine and geneTherapies, growing of biopharmaceutical research and development, rising healthcare spending, increasing focus on research and development. Major trends in the forecast period include integration of sensors and analytics, closed-system design, customization and modularity, artificial intelligence (ai) and automation, hybrid facilities.
The growing demand for pharmaceutical products is anticipated to drive the expansion of the single-use bioreactor market in the coming years. Pharmaceutical products encompass medications or drugs specifically designed to diagnose, prevent, treat, or cure diseases or medical conditions in humans or animals. Single-use bioreactors are crucial in pharmaceutical production, particularly in manufacturing biopharmaceuticals like antibodies, vaccines, and gene therapies. For instance, in March 2022, Atradius Collections, a US-based credit management firm, reported that the United States, which represents approximately 45% of the global pharmaceutical market and 22% of global production, experienced strong performance in 2022. The pharmaceutical output and sales grew by 3.2% year-over-year, reflecting the sector's ongoing resilience. Therefore, the increasing demand for pharmaceutical products is fueling the growth of the single-use bioreactor market.
The growth of the single-use bioreactor market is further driven by the rising number of clinical trials. Clinical trials, crucial for assessing new medical treatments, interventions, or drugs, benefit from the advantages offered by single-use bioreactors, including rapid scalability, reduced cross-contamination risk, and shorter setup times. With an increase in registered studies reported by ClinicalTrials.gov, reaching 464,218 in 2023 compared to 399,496 in 2021, the market is poised to capitalize on the dynamic needs of clinical trials, with 31% in the U.S. and 53% in non-U.S. locations contributing to this growth.
Product innovations are a significant trend gaining traction in the single-use bioreactor market. Leading companies are concentrating on launching cutting-edge products to drive market growth. For example, in September 2023, Getinge, a Sweden-based medical technology firm, unveiled the AppliFlex ST GMP, an advanced single-use bioreactor system aimed at facilitating the transition from research to clinical production in cell and gene therapy, as well as mRNA production. This turnkey solution encompasses consumables, verification tools, and GMP-compliant software, making it suitable for both clinical trials and production processes.
Technological advancements play a pivotal role, with companies developing state-of-the-art products such as X-platform bioreactors to stay competitive. Cytiva, a U.S.-based company, introduced X-platform bioreactors in April 2023, catering to single-use upstream bioprocessing needs. Equipped with the Figurate automation solution software, these bioreactors, available in sizes from 50 to 200 liters, aim to improve process efficiency by increasing production capacity, enhancing ergonomics, and streamlining supply chain operations.
In June 2023, Donaldson Company, Inc., a U.S.-based filtration company, acquired Univercells Technologies for $148 million. This acquisition enhances Donaldson's product portfolio, ensuring a comprehensive range of offerings in line with its life sciences strategy. Univercells Technologies, based in Belgium, specializes in single-use bioprocessing and bioreactor products.
Major companies operating in the single-use bio reactors market include CESCO Bioengineering Co Ltd, PBS Biotech Inc, Solida Biotechnology GmbH, ABEC Inc., Eppendorf AG, Sartorius Stedim Biotech Sa Ltd, Danaher Corporation Ltd, Thermo Fisher Scientific Inc., GE Healthcare, Merck Kgaa (Merck Millipore) Pvt Ltd, Distek Inc, Celltainer Biotech Bv Pvt.Ltd, Getinge AB, Pall Corporation, G&G Technologies Inc, SATAKE MultiMix Corporation, Bio-Age Equipment & Service Pvt.Ltd, Entegris Inc., Avantor Inc., Celartia, Cell Culture Company, Cytiva, Solaris Biotechnology srl., Cellexus International Ltd., Distek Inc., Infors AG, OmniBRx Biotechnologies, Xcellerex Inc., Applikon Biotechnology Inc., BBI-Biotech GmbH.
North America was the largest region in the single use bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single-use bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
A single-use bioreactor is a type of bioreactor that features a disposable bag instead of a traditional culture vessel. These bioreactors enable processors to utilize disposable technologies, including single-use bags, in steps that were traditionally reserved for stainless steel equipment.
The primary types of single-use bioreactors include stirred-tank SUBs (Single-Use Bioreactors), wave-induced SUBs, bubble-column SUBs, and other variations. Stirred-tank bioreactor designs, mimicking the functionality of traditional stirred-tank bioreactors, have gained increased market adoption. These bioreactors are employed in the production of various molecules such as vaccines, monoclonal antibodies, stem cells, and recombinant proteins, involving different cell types like mammalian cells, bacteria, and yeast. The applications of single-use bioreactors encompass research and development, process development, and bioproduction. End-users of these bioreactors include pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), academic and research institutes, as well as contract manufacturing organizations (CMOs).
The single-use bioreactors market research report is one of a series of new reports that provides single-use bioreactors market statistics, including single-use bioreactors industry global market size, regional shares, competitors with a single-use bioreactors market share, detailed single-use bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioreactors industry. This single-use bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The single-use bio reactors market size has grown rapidly in recent years. It will grow from $5.26 billion in 2024 to $6.23 billion in 2025 at a compound annual growth rate (CAGR) of 18.3%. The growth in the historic period can be attributed to biopharmaceutical industry growth, rapid bioprocess development, regulatory support, high adoption rates of precision medicine, rise in healthcare infrastructure.
The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $13.68 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to personalized medicine and geneTherapies, growing of biopharmaceutical research and development, rising healthcare spending, increasing focus on research and development. Major trends in the forecast period include integration of sensors and analytics, closed-system design, customization and modularity, artificial intelligence (ai) and automation, hybrid facilities.
The growing demand for pharmaceutical products is anticipated to drive the expansion of the single-use bioreactor market in the coming years. Pharmaceutical products encompass medications or drugs specifically designed to diagnose, prevent, treat, or cure diseases or medical conditions in humans or animals. Single-use bioreactors are crucial in pharmaceutical production, particularly in manufacturing biopharmaceuticals like antibodies, vaccines, and gene therapies. For instance, in March 2022, Atradius Collections, a US-based credit management firm, reported that the United States, which represents approximately 45% of the global pharmaceutical market and 22% of global production, experienced strong performance in 2022. The pharmaceutical output and sales grew by 3.2% year-over-year, reflecting the sector's ongoing resilience. Therefore, the increasing demand for pharmaceutical products is fueling the growth of the single-use bioreactor market.
The growth of the single-use bioreactor market is further driven by the rising number of clinical trials. Clinical trials, crucial for assessing new medical treatments, interventions, or drugs, benefit from the advantages offered by single-use bioreactors, including rapid scalability, reduced cross-contamination risk, and shorter setup times. With an increase in registered studies reported by ClinicalTrials.gov, reaching 464,218 in 2023 compared to 399,496 in 2021, the market is poised to capitalize on the dynamic needs of clinical trials, with 31% in the U.S. and 53% in non-U.S. locations contributing to this growth.
Product innovations are a significant trend gaining traction in the single-use bioreactor market. Leading companies are concentrating on launching cutting-edge products to drive market growth. For example, in September 2023, Getinge, a Sweden-based medical technology firm, unveiled the AppliFlex ST GMP, an advanced single-use bioreactor system aimed at facilitating the transition from research to clinical production in cell and gene therapy, as well as mRNA production. This turnkey solution encompasses consumables, verification tools, and GMP-compliant software, making it suitable for both clinical trials and production processes.
Technological advancements play a pivotal role, with companies developing state-of-the-art products such as X-platform bioreactors to stay competitive. Cytiva, a U.S.-based company, introduced X-platform bioreactors in April 2023, catering to single-use upstream bioprocessing needs. Equipped with the Figurate automation solution software, these bioreactors, available in sizes from 50 to 200 liters, aim to improve process efficiency by increasing production capacity, enhancing ergonomics, and streamlining supply chain operations.
In June 2023, Donaldson Company, Inc., a U.S.-based filtration company, acquired Univercells Technologies for $148 million. This acquisition enhances Donaldson's product portfolio, ensuring a comprehensive range of offerings in line with its life sciences strategy. Univercells Technologies, based in Belgium, specializes in single-use bioprocessing and bioreactor products.
Major companies operating in the single-use bio reactors market include CESCO Bioengineering Co Ltd, PBS Biotech Inc, Solida Biotechnology GmbH, ABEC Inc., Eppendorf AG, Sartorius Stedim Biotech Sa Ltd, Danaher Corporation Ltd, Thermo Fisher Scientific Inc., GE Healthcare, Merck Kgaa (Merck Millipore) Pvt Ltd, Distek Inc, Celltainer Biotech Bv Pvt.Ltd, Getinge AB, Pall Corporation, G&G Technologies Inc, SATAKE MultiMix Corporation, Bio-Age Equipment & Service Pvt.Ltd, Entegris Inc., Avantor Inc., Celartia, Cell Culture Company, Cytiva, Solaris Biotechnology srl., Cellexus International Ltd., Distek Inc., Infors AG, OmniBRx Biotechnologies, Xcellerex Inc., Applikon Biotechnology Inc., BBI-Biotech GmbH.
North America was the largest region in the single use bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single-use bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
A single-use bioreactor is a type of bioreactor that features a disposable bag instead of a traditional culture vessel. These bioreactors enable processors to utilize disposable technologies, including single-use bags, in steps that were traditionally reserved for stainless steel equipment.
The primary types of single-use bioreactors include stirred-tank SUBs (Single-Use Bioreactors), wave-induced SUBs, bubble-column SUBs, and other variations. Stirred-tank bioreactor designs, mimicking the functionality of traditional stirred-tank bioreactors, have gained increased market adoption. These bioreactors are employed in the production of various molecules such as vaccines, monoclonal antibodies, stem cells, and recombinant proteins, involving different cell types like mammalian cells, bacteria, and yeast. The applications of single-use bioreactors encompass research and development, process development, and bioproduction. End-users of these bioreactors include pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), academic and research institutes, as well as contract manufacturing organizations (CMOs).
The single-use bioreactors market research report is one of a series of new reports that provides single-use bioreactors market statistics, including single-use bioreactors industry global market size, regional shares, competitors with a single-use bioreactors market share, detailed single-use bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioreactors industry. This single-use bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Single-Use Bio Reactors Market Characteristics3. Single-Use Bio Reactors Market Trends and Strategies4. Single-Use Bio Reactors Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Single-Use Bio Reactors Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Single-Use Bio Reactors Market34. Recent Developments in the Single-Use Bio Reactors Market
5. Global Single-Use Bio Reactors Growth Analysis and Strategic Analysis Framework
6. Single-Use Bio Reactors Market Segmentation
7. Single-Use Bio Reactors Market Regional and Country Analysis
8. Asia-Pacific Single-Use Bio Reactors Market
9. China Single-Use Bio Reactors Market
10. India Single-Use Bio Reactors Market
11. Japan Single-Use Bio Reactors Market
12. Australia Single-Use Bio Reactors Market
13. Indonesia Single-Use Bio Reactors Market
14. South Korea Single-Use Bio Reactors Market
15. Western Europe Single-Use Bio Reactors Market
16. UK Single-Use Bio Reactors Market
17. Germany Single-Use Bio Reactors Market
18. France Single-Use Bio Reactors Market
19. Italy Single-Use Bio Reactors Market
20. Spain Single-Use Bio Reactors Market
21. Eastern Europe Single-Use Bio Reactors Market
22. Russia Single-Use Bio Reactors Market
23. North America Single-Use Bio Reactors Market
24. USA Single-Use Bio Reactors Market
25. Canada Single-Use Bio Reactors Market
26. South America Single-Use Bio Reactors Market
27. Brazil Single-Use Bio Reactors Market
28. Middle East Single-Use Bio Reactors Market
29. Africa Single-Use Bio Reactors Market
30. Single-Use Bio Reactors Market Competitive Landscape and Company Profiles
31. Single-Use Bio Reactors Market Other Major and Innovative Companies
35. Single-Use Bio Reactors Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Single-Use Bio Reactors Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on single-use bio reactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for single-use bio reactors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single-use bio reactors market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Stirred-Tank SUBs; Wave-Induced SUBs; Bubble-Column SUBs; Other Types2) by Molecule Type: Vaccines; Monoclonal Antibodies; Stem Cells; Recombinant Proteins
3) by Cell Type: Mammalian Cell; Bacteria; Yeast
4) by Application: Research and Development (R&D); Process Development; Bioproduction
5) by End User: Pharmaceutical and Biopharmaceutical Companies; Contract Research Organizations (CRO); Academic and Research Institutes; Contract Manufacturing Organizations (CMO)
Subsegments:
1) by Stirred-Tank SUBs: Single-Use Stirred-Tank Bioreactors; Batch Stirred-Tank SUBs; Continuous Stirred-Tank SUBs2) by Wave-Induced SUBs: Wave-Mixed Bioreactors; Disposable Wave Bioreactors
3) by Bubble-Column SUBs: Aerated Bubble-Column SUBs; Non-Aerated Bubble-Column SUBs
4) by Other Types: Fixed-Bed Bioreactors; Rotating Bioreactors; Photobioreactors
Key Companies Mentioned: CESCO Bioengineering Co Ltd; PBS Biotech Inc; Solida Biotechnology GmbH; ABEC Inc.; Eppendorf AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Single-Use Bio Reactors market report include:- CESCO Bioengineering Co Ltd
- PBS Biotech Inc
- Solida Biotechnology GmbH
- ABEC Inc.
- Eppendorf AG
- Sartorius Stedim Biotech Sa Ltd
- Danaher Corporation Ltd
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Merck Kgaa (Merck Millipore) Pvt Ltd
- Distek Inc
- Celltainer Biotech Bv Pvt.Ltd
- Getinge AB
- Pall Corporation
- G&G Technologies Inc
- SATAKE MultiMix Corporation
- Bio-Age Equipment & Service Pvt.Ltd
- Entegris Inc.
- Avantor Inc.
- Celartia
- Cell Culture Company
- Cytiva
- Solaris Biotechnology srl.
- Cellexus International Ltd.
- Distek Inc.
- Infors AG
- OmniBRx Biotechnologies
- Xcellerex Inc.
- Applikon Biotechnology Inc.
- BBI-Biotech GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 6.23 Billion |
| Forecasted Market Value ( USD | $ 13.68 Billion |
| Compound Annual Growth Rate | 21.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
